{
    "2018-05-06": [
        [
            {
                "time": "2018-03-15",
                "original_text": "3 Reasons Regeneron Stock Could Start Climbing Again",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "stock",
                        "climbing"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "FDA Oks Tafinlar-Mekinist Combination For BRAF-mutated Anaplastic Thyroid Cancer",
                "features": {
                    "keywords": [
                        "FDA",
                        "Tafinlar-Mekinist",
                        "BRAF-mutated",
                        "Anaplastic Thyroid Cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}